HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Release of vasoactive intestinal peptide during hyperdynamic sepsis in dogs.

Abstract
Vasoactive intestinal peptide (VIP) is a potent vasodilator that has been reported to be a mediator of the hemodynamic changes in endotoxin-induced hypodynamic septic shock. We investigated the release of VIP in a hyperdynamic model of sepsis in awake, conscious dogs similar to that of sepsis in human beings. Sepsis was induced by intraperitoneal implantation of a fibrin clot containing live Escherichia coli (0.9 +/- 0.2 X 10(9) organisms per kilogram of body weight). All dogs developed hyperdynamic sepsis with increased cardiac output and decreased systemic vascular resistance. During the first 24 hours of sepsis, VIP was released without a concomitant decrease in blood pressure, suggesting that during septic shock it was released by a direct mechanism rather than as a result of hypotension. During peak VIP release (2 to 4 hours after induction of sepsis) no decreases in systemic vascular resistance or mean arterial pressure were observed. This suggests that mediators other than VIP may be responsible for the vasodilation observed during sepsis. The precise role of VIP during sepsis is therefore yet to be clarified.
AuthorsM Fuortes, M A Blank, T M Scalea, T W Pollock, B M Jaffe
JournalSurgery (Surgery) Vol. 104 Issue 5 Pg. 894-8 (Nov 1988) ISSN: 0039-6060 [Print] United States
PMID3187902 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Vasoactive Intestinal Peptide
Topics
  • Animals
  • Blood Pressure
  • Cardiac Output
  • Disease Models, Animal
  • Dogs
  • Female
  • Heart Rate
  • Hemodynamics
  • Male
  • Portal Vein
  • Shock, Septic (blood, physiopathology)
  • Vascular Resistance
  • Vasoactive Intestinal Peptide (blood, isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: